-
'Aura' battles leap from social media to Latin America streets
-
Australia lose three wickets after skittling Bangladesh for 64
-
US, Canada fail to reach trade pact to avert Trump tariffs
-
Bangladesh all out for 64 in 2nd Test after Starc masterclass
-
Sudan farms lie barren as El Nino leaves Nile banks dry
-
Odyssey effect: stars sell Greece to a new wave of US tourists
-
Arctic shipping a daunting prospect in hotly contested region
-
South Korea to send first container ship through Arctic route
-
In US, rare earths extracted from coal mine wastewater
-
Starc takes 5-11 to leave Bangladesh reeling in 2nd Test
-
Nakashima pounds Fritz, Bejlek beats Keys in Cincinnati upsets
-
Injured Rune withdraws from US Open
-
Canadian negotiator says 'more work to do' on US trade deal
-
Nakashima knocks out Fritz to reach Cincinnati semi-finals
-
'Solid' Clark takes solo lead at BMW Championship
-
Ukraine says 'cynical' Russian strike on shopping centre killed 16
-
Arteta hails Arsenal's desire after perfect start to title defence
-
TikTok to pay $400 mn settlement in US children's privacy case
-
Betis down Real Sociedad in La Liga opener
-
MLS fines Messi for striking an opponent
-
Mexican governor resumes job despite US drug charges
-
Gouiri double fires Marseille past Strasbourg in Ligue 1 opener
-
Arsenal rout Coventry to open Premier League season in style
-
Mavericks buy out Thompson, now reportedly bound for Heat
-
Giant-killer Bejlek overhauls Keys to reach Cincinnati semi-finals
-
England v Pakistan first Test: Three talking points
-
Man Utd agree deal for Brighton midfielder Baleba: reports
-
US, Canada push to seal trade deal as deadline nears
-
Werro wins Lausanne 800m, well off world record pace
-
One dead, three wounded after sword attack at Swedish high school
-
China mulls bid to host 2028 UN climate talks: sources
-
Ukraine says 'cynical' Russian strike on shopping centre killed 15
-
Jones becomes third Englishman to join Inter this summer
-
US Supreme Court allows White House ballroom construction for now
-
Mexican governor wanted on US drug charges returns to job
-
Root hails emerging fast bowlers as England thrash Pakistan
-
Bolivia's Paz forced to fire economy minister in mid-crisis
-
Brazil's Lula urges tariffs resolution in call with Trump
-
A-Rod ups T-Wolves stake in $4.5bn ownership change
-
Ukraine says 'cynical' Russian strike on shopping centre killed 14
-
UK court orders Prince Harry, others to pay Daily Mail initial £9.5mn
-
Heatwave-hit Europe logs over 30,000 excess summer deaths: first figures
-
'Grateful' ex-world champion Alaphilippe retires from cycling
-
Give LIV Golf 'one more shot,' says DeChambeau
-
US, Canada work to wrap up trade deal ahead of looming deadline
-
Duplantis hits the high notes for athletics anthem
-
Malaysia's JDT claim unbeaten run world record
-
Malaysia's JDT claims unbeaten run world record
-
At least 2 teens seriously wounded in sword attack at Swedish school
-
Bolivian economy minister fired after Congress vote
TailorMed CEO Srulik Dvorsky to Lead Panel Session on the Impact of Technology on Specialty Pharmacy Affordability Programs at NASP 2025 Conference
Discussion Will Explore How Emerging Innovations Can Lead to Improved Clinical and Financial Outcomes
NEW YORK, NY / ACCESS Newswire / September 3, 2025 / TailorMed, a leading healthcare technology company, announced that co-founder and chief executive officer Srulik Dvorsky will moderate a panel session on patient affordability initiatives during the National Association of Specialty Pharmacy (NASP) 2025 Annual Meeting & Expo at the Gaylord Resort in Denver, Colorado. The conference takes place September 14-17, 2025. Dvorsky's session, "Leveraging Technology to Scale Affordability Programs in Specialty Pharmacy," will take place on September 14 at 10:10 a.m. MT.
During the session, Dvorsky will be joined by leaders from CenterWell, Prime Therapeutics, and Alivia Health. The panelists will examine how technology is improving access to financial assistance for specialty treatments, resulting in better patient outcomes, operational efficiency, and pharmacy performance.
"Despite the many financial assistance programs available, finding and enrolling patients in these resources is often manual and time-consuming, leading to treatment delays and abandonment," said Dvorsky. "This panel session will educate attendees on how pharmacies can streamline and automate affordability workflows, improving adherence, elevating care quality, and increasing revenue."
TailorMed's expansive network brings together leading pharmacies, providers, life science companies, and other stakeholders to broaden access to financial resources. Since its inception, the company has secured more than $5 billion in financial assistance for patients.
TailorMed representatives will be available throughout the conference at booth #426 for discussions and demonstrations of their affordability solutions.
To learn more about TailorMed, please visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence. TailorMed's innovations in healthcare are transforming how stakeholders-patients, providers, pharmacies, life sciences, and payers-work together to ensure that every patient, across all medical conditions, can receive the treatment they need without delay. TailorMed's enterprise solution manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes. Thanks to its partnerships with life sciences, TailorMed creates unparalleled automation through direct integration with manufacturer assistance programs. With the nation's largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed powers organizations to create a seamless patient experience. Learn more at tailormed.co.
![]()
Contact:
Jennifer Martin
[email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
M.Robinson--AT